✦ LIBER ✦

Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?

✍ Scribed by James W. Denham; Allison Steigler; Chantelle Wilcox; David S. Lamb; David Joseph; Chris Atkinson; Keen-Hun Tai; Nigel A. Spry; Paul S. Gleeson; Catherine D'Este

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 354 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24484

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer-specific survival and predictors

Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy

✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme

Presalvage prostate-specific antigen (PS

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

✍ Philippe E. Spiess; Andrew K. Lee; Dan Leibovici; Xuemei Wang; Kim-Anh Do; Louis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Predictors of mortality after androgen-d

Predictors of mortality after androgen-deprivation therapy in patients with rapidly rising prostate-specific antigen levels after local therapy for prostate cancer

✍ Neesha A. Rodrigues; Ming-Hui Chen; William J. Catalona; Kimberly A. Roehl; Jero 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Calculated prostate carcinoma volume : T

Calculated prostate carcinoma volume : The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter

✍ Anthony V. D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: In this study, the authors evaluated whether a clinically relevant stratification of prostate specific antigen (psa) failure free survival (bned) after definitive local therapy could be made for patients with prostate carcinoma clinically classified as t1 or t2 and pretreatment psa l

Locally advanced prostate cancer: Bioche

Locally advanced prostate cancer: Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Bernardo Rocco; Epifanio Scardino; Ottavio de Cobelli 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

I n the article by Bruchovsky et al., 1 intermittent androgen sup- pression was evaluated in patients with clinically locally advanced prostate cancer who developed biochemical disease recurrence after radiotherapy. We consider it to be of utmost important to improve currently existing knowledge re

Locally advanced prostate cancer—biochem

Locally advanced prostate cancer—biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

✍ Nicholas Bruchovsky; Laurence Klotz; Juanita Crook; S. Larry Goldenberg 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views